Nonalcoholic fatty liver and metabolic syndrome in Italy: results from a multicentric study of the Italian Arteriosclerosis society

Alberto Notarbartolo, Maurizio Averna, Maurizio Soresi, Angelo Baldassare Cefalu', Luigi Cattin, Maurizio Fonda, Scipione Martini, Renato Fellin, Enzo Manzato, Giovanni Battista Vigna

    Risultato della ricerca: Article

    23 Citazioni (Scopus)

    Abstract

    Nonalcoholic fatty liver disease (NAFLD) is associated with all the components of metabolic syndrome (MS) and might to be considered an additional component of MS itself. The Italian Society for the Study of Atherosclerosis (SISA) in 2005 started a research project aimed to study the NAFLD, using ultrasound (US), in nondiabetic MS subjects matching at least one of the ATP III criteria for HDL-C or triglycerides [TG]. Prevalence of US-NAFLD and its associated risk factors and prevalence of hypertransaminasemia and its possible determinants were evaluated. NAFLD prevalence was 0.78. Men with steatosis compared to men without steatosis were younger (P <0.05) with higher TG (P <0.03), homeostasis model assessment insulin resistance (HOMA-R) (P <0.003), and visceral fat thickness (VFT) (P <0.0001). Women with steatosis showed higher TG (P <0.05), HOMA-R (P <0.04), VFT (P <0.0001), and lower age (P <0.05). At multivariate analyses, VFT (P <0.0001), HOMA-R (P <0.02), and TG/HDL (P <0.05) were associated with severity of NAFLD. Age (P <0.05), LogTG (P <0.005), and VFT (P <0.01) were associated with higher ALT. The US prevalence of steatosis in this study (0.78) is the highest reported in patients with MS. Considering the exclusion of severe obese and diabetic patients and the recruitment criteria, this finding highlights the prominent role played by the alterations of lipid metabolism in the pathogenesis of NAFLD.
    Lingua originaleEnglish
    pagine (da-a)241-249
    Numero di pagine9
    RivistaActa Diabetologica
    Volume50
    Stato di pubblicazionePublished - 2012

    Fingerprint

    Arteriosclerosis
    Italy
    Intra-Abdominal Fat
    Triglycerides
    Insulin Resistance
    Homeostasis
    Lipid Metabolism
    Patient Selection
    Non-alcoholic Fatty Liver Disease
    Atherosclerosis
    Multivariate Analysis
    Adenosine Triphosphate
    Research

    All Science Journal Classification (ASJC) codes

    • Internal Medicine
    • Endocrinology
    • Endocrinology, Diabetes and Metabolism

    Cita questo

    Nonalcoholic fatty liver and metabolic syndrome in Italy: results from a multicentric study of the Italian Arteriosclerosis society. / Notarbartolo, Alberto; Averna, Maurizio; Soresi, Maurizio; Cefalu', Angelo Baldassare; Cattin, Luigi; Fonda, Maurizio; Martini, Scipione; Fellin, Renato; Manzato, Enzo; Vigna, Giovanni Battista.

    In: Acta Diabetologica, Vol. 50, 2012, pag. 241-249.

    Risultato della ricerca: Article

    @article{15c44fdbb1fc454a8aaf716ca82a80b7,
    title = "Nonalcoholic fatty liver and metabolic syndrome in Italy: results from a multicentric study of the Italian Arteriosclerosis society",
    abstract = "Nonalcoholic fatty liver disease (NAFLD) is associated with all the components of metabolic syndrome (MS) and might to be considered an additional component of MS itself. The Italian Society for the Study of Atherosclerosis (SISA) in 2005 started a research project aimed to study the NAFLD, using ultrasound (US), in nondiabetic MS subjects matching at least one of the ATP III criteria for HDL-C or triglycerides [TG]. Prevalence of US-NAFLD and its associated risk factors and prevalence of hypertransaminasemia and its possible determinants were evaluated. NAFLD prevalence was 0.78. Men with steatosis compared to men without steatosis were younger (P <0.05) with higher TG (P <0.03), homeostasis model assessment insulin resistance (HOMA-R) (P <0.003), and visceral fat thickness (VFT) (P <0.0001). Women with steatosis showed higher TG (P <0.05), HOMA-R (P <0.04), VFT (P <0.0001), and lower age (P <0.05). At multivariate analyses, VFT (P <0.0001), HOMA-R (P <0.02), and TG/HDL (P <0.05) were associated with severity of NAFLD. Age (P <0.05), LogTG (P <0.005), and VFT (P <0.01) were associated with higher ALT. The US prevalence of steatosis in this study (0.78) is the highest reported in patients with MS. Considering the exclusion of severe obese and diabetic patients and the recruitment criteria, this finding highlights the prominent role played by the alterations of lipid metabolism in the pathogenesis of NAFLD.",
    author = "Alberto Notarbartolo and Maurizio Averna and Maurizio Soresi and Cefalu', {Angelo Baldassare} and Luigi Cattin and Maurizio Fonda and Scipione Martini and Renato Fellin and Enzo Manzato and Vigna, {Giovanni Battista}",
    year = "2012",
    language = "English",
    volume = "50",
    pages = "241--249",
    journal = "Acta Diabetologica",
    issn = "0940-5429",
    publisher = "Springer-Verlag Italia",

    }

    TY - JOUR

    T1 - Nonalcoholic fatty liver and metabolic syndrome in Italy: results from a multicentric study of the Italian Arteriosclerosis society

    AU - Notarbartolo, Alberto

    AU - Averna, Maurizio

    AU - Soresi, Maurizio

    AU - Cefalu', Angelo Baldassare

    AU - Cattin, Luigi

    AU - Fonda, Maurizio

    AU - Martini, Scipione

    AU - Fellin, Renato

    AU - Manzato, Enzo

    AU - Vigna, Giovanni Battista

    PY - 2012

    Y1 - 2012

    N2 - Nonalcoholic fatty liver disease (NAFLD) is associated with all the components of metabolic syndrome (MS) and might to be considered an additional component of MS itself. The Italian Society for the Study of Atherosclerosis (SISA) in 2005 started a research project aimed to study the NAFLD, using ultrasound (US), in nondiabetic MS subjects matching at least one of the ATP III criteria for HDL-C or triglycerides [TG]. Prevalence of US-NAFLD and its associated risk factors and prevalence of hypertransaminasemia and its possible determinants were evaluated. NAFLD prevalence was 0.78. Men with steatosis compared to men without steatosis were younger (P <0.05) with higher TG (P <0.03), homeostasis model assessment insulin resistance (HOMA-R) (P <0.003), and visceral fat thickness (VFT) (P <0.0001). Women with steatosis showed higher TG (P <0.05), HOMA-R (P <0.04), VFT (P <0.0001), and lower age (P <0.05). At multivariate analyses, VFT (P <0.0001), HOMA-R (P <0.02), and TG/HDL (P <0.05) were associated with severity of NAFLD. Age (P <0.05), LogTG (P <0.005), and VFT (P <0.01) were associated with higher ALT. The US prevalence of steatosis in this study (0.78) is the highest reported in patients with MS. Considering the exclusion of severe obese and diabetic patients and the recruitment criteria, this finding highlights the prominent role played by the alterations of lipid metabolism in the pathogenesis of NAFLD.

    AB - Nonalcoholic fatty liver disease (NAFLD) is associated with all the components of metabolic syndrome (MS) and might to be considered an additional component of MS itself. The Italian Society for the Study of Atherosclerosis (SISA) in 2005 started a research project aimed to study the NAFLD, using ultrasound (US), in nondiabetic MS subjects matching at least one of the ATP III criteria for HDL-C or triglycerides [TG]. Prevalence of US-NAFLD and its associated risk factors and prevalence of hypertransaminasemia and its possible determinants were evaluated. NAFLD prevalence was 0.78. Men with steatosis compared to men without steatosis were younger (P <0.05) with higher TG (P <0.03), homeostasis model assessment insulin resistance (HOMA-R) (P <0.003), and visceral fat thickness (VFT) (P <0.0001). Women with steatosis showed higher TG (P <0.05), HOMA-R (P <0.04), VFT (P <0.0001), and lower age (P <0.05). At multivariate analyses, VFT (P <0.0001), HOMA-R (P <0.02), and TG/HDL (P <0.05) were associated with severity of NAFLD. Age (P <0.05), LogTG (P <0.005), and VFT (P <0.01) were associated with higher ALT. The US prevalence of steatosis in this study (0.78) is the highest reported in patients with MS. Considering the exclusion of severe obese and diabetic patients and the recruitment criteria, this finding highlights the prominent role played by the alterations of lipid metabolism in the pathogenesis of NAFLD.

    UR - http://hdl.handle.net/10447/73834

    M3 - Article

    VL - 50

    SP - 241

    EP - 249

    JO - Acta Diabetologica

    JF - Acta Diabetologica

    SN - 0940-5429

    ER -